Adaptive Biotechnologies Corporation
ADPT
$24.66
$0.321.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -55.34% | 32.89% | 59.48% | 129.82% | 44.58% |
| Total Depreciation and Amortization | -17.93% | -18.90% | -5.69% | -4.05% | -10.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 110.70% | 1.36% | 2.28% | -5.71% | -33.68% |
| Change in Net Operating Assets | 104.18% | 61.00% | -180.28% | -159.98% | -287.72% |
| Cash from Operations | 48.51% | 66.52% | 116.45% | 73.67% | 28.16% |
| Capital Expenditure | -80.76% | 36.78% | -695.00% | -18.90% | 62.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,157.06% | -62.96% | -134.31% | 214.19% | -47.40% |
| Cash from Investing | -1,399.37% | -64.25% | -137.31% | 226.90% | -43.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 234.29% | 37.59% | 16,953.54% | 4,110.00% | 5,266.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8,731.55% | 37.59% | 16,953.54% | 4,110.00% | 5,266.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,335.09% | 179.76% | 58.49% | 154.47% | 34.42% |